Our capabilities and experiences

IBR AG implemented several post marketing surveillances using Electronic Data Capture (EDC) for international pharmaceutical industry. Two of the surveillances were developed to fulfil obligation of EMEA to increase compliance to the SPC and to collect additional safety data as part of the post marketing risk management program.

IBR AG is following developments in risk management and pharmacovigilance closely and is able to support pharmaceutical companies in other aspects of risk management such as reconciliation of adverse events with the drug safety database or set up of reports to detect safety signals.